Ackermann Medical Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
- Paid Up Capital ₹ 0.10 M
- Company Age 8 Year, 11 Months
- Last Filing with ROC 31 Mar 2024
- Revenue Growth -86.39%
- Profit Growth -172.22%
- Ebitda -499.39%
- Net Worth -52.37%
- Total Assets 7.37%
About Ackermann Medical
Ackermann Medical Private Limited (AMPL) is a Private Limited Indian Non-Government Company incorporated in India on 03 February 2016 (Eight years and 11 months 27 days old ). Its registered office is in Delhi, India.
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Sharbani Tarat, Peter Grassl, and Manoj Choudhury serve as directors at the Company.
Company Details
- Location
Delhi, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
-
- Social Media-
Corporate Identity Details
- CIN/LLPIN
U74999DL2016PTC290523
- Company No.
290523
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
03 Feb 2016
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Delhi
Industry
What products or services does Ackermann Medical Private Limited offer?
Ackermann Medical Private Limited offers a wide range of products and services, including Medical Laboratory Instruments, IVDs & Analyzers, Urological & Obstetrics Instruments, Gynaecological Equipment.
Who are the key members and board of directors at Ackermann Medical?
Board Members (3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Sharbani Tarat  | Director | 22-Dec-2021 | Current |
Peter Grassl  | Additional Director | 22-Dec-2021 | Current |
| Manoj Choudhury | Director | 03-Feb-2016 | Current |
Financial Performance of Ackermann Medical.
Ackermann Medical Private Limited, for the financial year ended 2021, experienced significant reduction in revenue, with a 86.39% decrease. The company also saw a substantial fall in profitability, with a 172.22% decrease in profit. The company's net worth observed a substantial decline by a decrease of 52.37%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Ackermann Medical?
In 2021, Ackermann Medical had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Ackermann Medical?
Unlock and access historical data on people associated with Ackermann Medical, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Ackermann Medical, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Ackermann Medical's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
